Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
The Thermo Fisher Scientific Amplitude Solution is a high-throughput automated molecular diagnostic testing solution. It can help laboratories quickly scale COVID-19 PCR testing to changes in demand volume, offering maximum throughput with minimal hands-on time, equipment, and staffing.
As the world leader in serving science, Thermo Fisher Scientific has brought together industry-leading products into a high-throughput diagnostic solution with the convenience of purchasing a secured supply of assays and consumables directly from a single-source supplier. Your initial purchase comes with an up-front monthly delivery of reagents for your laboratory’s needs over the first year. Our all-inclusive service partnership will handle every detail of the process to ensure a seamless installation and offers 24/7, 365-day priority access to reliable experts you can count on for any issues that arise now and into the future.
All-inclusive service partnershipOur service team will be the single point of contact you can rely on to handle everything from installation, which includes performance checking, and training to optimizing workflow applications, software, and all instrument components to ensure your lab is quickly performing at its peak. |
Get answers and keep movingWe offer a rapid response 24/7, 365 days a year for both in-person and remote troubleshooting depending on your specific needs. Our service partnership includes planned maintenance visits to solve problems before they arise and on-hand locally stocked parts for those unavoidable repairs to minimize downtime and keep your lab moving forward in the fight against COVID-19. |
* 365-day, 24/7 priority technical support is available in the English language only. Rapid-response on-site support within 24 hours is subject to regional availability.
For In Vitro Diagnostic Use Only. For Prescription Use Only. Special Authorization.
Authorized by Health Canada under the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act.